In the last decades, the large use of several effective vaccines has dramatically reduced the incidence of community acquired pneumonia (CAP) in infants and children. Moreover, the availability of new antibiotics effective against emerging resistant strains of bacteria has greatly improved the early and long-term prognosis of this disease.
Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age / Esposito, Susanna; Dal Canto, Giulia; Caramia, Maria Rosaria; Fainardi, Valentina; Pisi, Giovanna; Principi, Nicola. - In: EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. - ISSN 1744-8336. - 20:1(2022), pp. 45-51. [10.1080/14787210.2021.1927710]
Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age
Esposito, Susanna;Dal Canto, Giulia;Caramia, Maria Rosaria;Fainardi, Valentina;
2022-01-01
Abstract
In the last decades, the large use of several effective vaccines has dramatically reduced the incidence of community acquired pneumonia (CAP) in infants and children. Moreover, the availability of new antibiotics effective against emerging resistant strains of bacteria has greatly improved the early and long-term prognosis of this disease.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
